Stock EW EDWARDS LIFESCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
86.89 USD -1.14% Intraday chart for Edwards Lifesciences Corporation -1.24% +13.95%
May. 23 Some of the biggest splits in Corporate America RE
May. 22 Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98 MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Some of the biggest splits in Corporate America
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98
Edwards Lifesciences : First Quarter 2024 Fact Sheet
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing
Edwards Lifesciences Faces EU Antitrust Complaint By Meril
Edwards Lifesciences hit with Meril's EU antitrust complaint
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing
Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $99 From $94
UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating
Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85
Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86
Well, it isn't as bad as feared...
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EW Stock
  4. News Edwards Lifesciences Corporation
  5. Other languages